캐리어 스크리닝 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Carrier Screening Market size is expected to reach USD 5.76 Billion in 2034 from USD 1.93 Billion (2025) growing at a CAGR of 12.91% during 2026-2034.

The global carrier screening market is witnessing rapid growth due to the increasing importance of genetic testing in reproductive health. Carrier screening tests help identify individuals who carry genetic mutations that may cause inherited diseases in their children. These tests are commonly used for conditions such as cystic fibrosis, spinal muscular atrophy, and other genetic disorders.

The growth of this market is driven by rising awareness about genetic disorders and the growing demand for early detection of inherited conditions. Advances in genomic technologies and the decreasing cost of genetic testing have made carrier screening more accessible to patients. Healthcare providers are increasingly recommending these tests to couples planning pregnancy.

Looking ahead, the carrier screening market is expected to expand significantly as personalized medicine and genetic testing become more widely adopted. Advances in next-generation sequencing technologies will improve the accuracy and efficiency of screening tests. Increasing investments in genetic research and expanding healthcare infrastructure will also support the long-term growth of this market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Expanded Carrier Screening
• Targeted Disease Carrier Screening

By Medical Condition

• Cystic Fibrosis
• Tay-Sachs
• Gaucher Disease
• Sickle Cell Disease
• Spinal Muscular Atrophy
• Other

By Technology

• DNA Sequencing
• Polymerase Chain Reaction
• Microarrays
• Other

By End-user

• Hospitals
• Laboratories
• Physician Offices & Clinics
• Other

COMPANIES PROFILED

• Myriad Genetics Inc, Cepheid, Illumina, Thermo Fisher Scientific Inc, F HoffmannLa Roche Ltd, Laboratory Corporation of America Holdings, Otogenetics, MedGenome, GeneTech, Centogene NV
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARRIER SCREENING MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Expanded Carrier Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Targeted Disease Carrier Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARRIER SCREENING MARKET: BY MEDICAL CONDITION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Medical Condition
• 5.2. Cystic Fibrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Tay-Sachs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Gaucher Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Sickle Cell Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Spinal Muscular Atrophy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARRIER SCREENING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. DNA Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Polymerase Chain Reaction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARRIER SCREENING MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Physician Offices & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CARRIER SCREENING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Medical Condition
  • 8.2.3 By Technology
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Medical Condition
  • 8.3.3 By Technology
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Medical Condition
  • 8.4.3 By Technology
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Medical Condition
  • 8.5.3 By Technology
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Medical Condition
  • 8.6.3 By Technology
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CARRIER SCREENING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Myriad Genetics Inc
  • 10.2.2 Cepheid
  • 10.2.3 Illumina
  • 10.2.4 Thermo Fisher Scientific Inc
  • 10.2.5 F. Hoffmann-La Roche Ltd
  • 10.2.6 Laboratory Corporation Of America Holdings
  • 10.2.7 Otogenetics
  • 10.2.8 MedGenome
  • 10.2.9 GeneTech
  • 10.2.10 Centogene N.V